Siemens Medical Systems has ceded responsibility for global cyclotronsales and marketing to its PET partner, Computer Technology Imaging(CTI) of Knoxville, TN. The move enables Siemens to focus on marketingits PET products, according to Thomas Cafarella,
Siemens Medical Systems has ceded responsibility for global cyclotronsales and marketing to its PET partner, Computer Technology Imaging(CTI) of Knoxville, TN. The move enables Siemens to focus on marketingits PET products, according to Thomas Cafarella, group vice presidentof Siemens' nuclear medicine unit in Hoffman Estates, IL.
Siemens acquired marketing rights to CTI's PET scanner and RadioisotopeDelivery System (RDS) cyclotron through an investment and marketingagreement in 1987 (SCAN 11/25/87). Siemens will continue to handlesales and support of the ECAT PET line and will arrange for CTIsupport of cyclotron service contracts currently in place.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 5th 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 5th 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Reducing the Interval Breast Cancer Rate of Screening DBT: Can AI Have an Impact?
August 5th 2025In a retrospective review of screening digital breast tomosynthesis (DBT) exams for over 200 women with interval breast cancers, researchers found that AI provided accurate localization of cancers in 32.6 percent of the cases.